The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...
Revenue: Total revenue was $2.1 million for the quarter ended September 30, 2024, comprised of $0.6 million in net product revenue for neffy sales, which reflects revenues from only one week following ...
Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...
One specific type of viral exanthem that dermatologists have seen with COVID is a morbilliform rash, meaning a measles-like ...
Verywell Health on MSN1 年
The Best Options for Hives Treatment
Medically reviewed by Jurairat J. Molina, MD Acute urticaria (hives) is a common skin condition that affects up to 20% of people at some point in their lives. It can transition into chronic urticaria ...